Fig. 3

Frequency and Maximum Scores for Anticholinergic Drugs across Seven Anticholinergic Burden Scales. Frequency and Maximum Scores for Anticholinergic Drugs across Seven Anticholinergic Burden Scales. This figure presents the anticholinergic burden scores assigned to various drugs based on seven different scales, which are highlighted using yellow and pink shading. Yellow represents lower anticholinergic burden scores (1 or 2), while pink indicates higher anticholinergic burden scores (3). Each row corresponds to a specific drug, and the columns list the anticholinergic scores from each scale. The drugs are organized to display their variability in scoring across scales, highlighting differences in how each scale evaluates anticholinergic burden. Drugs with a score of 3 (high anticholinergic effect) on multiple scales are shaded in pink, indicating stronger anticholinergic potential according to those scales. This visualization helps to contrast the scoring systems and identify discrepancies in drug classification across the scales. Abbreviations: ACB Anticholinergic Cognitive Burden, ARS: Anticholinergic Risk Scale, ADS Anticholinergic Drug Scale, ALS: Anticholinergic Load Scale, CrAS Clinician-rated Anticholinergic Scale, AEC Anticholinergic Effect on Cognition, CALS CRIDECO Anticholinergic Load Scale